Moderna | MRNA

Stock Price
126.90
Daily Change
-1.55%
Yearly
-12.69%
Q2 Forecast
126.73
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Acadia Pharmaceuticals 23.99 0.02 0.08% 31.31%
Acorda Therapeutics 10.21 -0.01 -0.10% 2,712.67%
Agios Pharmaceuticals 26.82 0.76 2.92% 37.19%
Alnylam Pharmaceuticals 192.96 0.66 0.34% 43.99%
Amgen 221.22 -0.66 -0.30% -10.22%
Arrowhead Research 36.12 1.12 3.20% 3.53%
Biogen 299.79 -2.34 -0.77% 49.09%
Bluebird Bio 3.73 0.02 0.54% 3.32%
BioMarin Pharmaceutical 92.01 0.28 0.31% 17.66%
Esperion Therapeutics 1.37 0.02 1.48% -77.90%
Gilead Sciences 76.20 -1.52 -1.96% 21.84%
GlaxoSmithKline 1,391.40 9.40 0.68% -19.09%
Intercept Pharmaceuticals 11.31 0.12 1.07% -22.32%
Incyte Corp 61.71 -0.66 -1.06% -17.62%
Ionis Pharmaceuticals 43.33 1.07 2.53% 23.69%
Mirati Therapeutics 40.50 1.09 2.77% -31.23%
Puma Biotechnology 3.54 -0.03 -0.84% 32.09%
Ultragenyx Pharmaceutical 51.48 0.23 0.45% -3.29%
Regeneron Pharmaceuticals 748.16 -2.13 -0.28% 21.85%
Seattle Genetics 195.47 0.28 0.14% 35.40%
Sangamo BioSciences 1.26 0.10 8.62% -68.66%
Sarepta Therapeutics 128.60 2.43 1.93% 79.21%
United Therapeutics 220.25 1.37 0.63% -3.66%
Vertex Pharmaceuticals 330.46 -4.01 -1.20% 21.56%

Indexes Price Day Year
USNDX 14564 1.60 0.01% 15.45%
US500 4288 10.06 0.24% 4.17%

Moderna

Moderna Inc traded at $126.90 this Tuesday June 6th, decreasing $2.00 or 1.55 percent since the previous trading session. Looking back, over the last four weeks, Moderna lost 3.68 percent. Over the last 12 months, its price fell by 12.69 percent. Looking ahead, we forecast Moderna Inc to be priced at 126.73 by the end of this quarter and at 116.02 in one year, according to Trading Economics global macro models projections and analysts expectations.

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.